On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus.

About Us

Take Charge of Your Health: About iHealth

iHealth is dedicated to helping people lead healthier lives.

Our Goal

Our goal is to make it as easy as possible for individuals of all ages to take a more active role in managing their health.

Our Approach

We do this by designing and manufacturing innovative, consumer-friendly, mobile personal healthcare products that connect to the cloud.

iHealth products are easy to use, making it simple for consumers to accurately measure, track, and share a full range of health vitals.

By automatically connecting the data through the cloud, consumers are able to see a more comprehensive view of their vitals and easily share information with healthcare professionals or loved ones.

iHealth's award-winning line of products includes:

  • blood pressure monitors;
  • blood glucose monitors;
  • body analysis scales;
  • pulse oximeters; and
  • activity and sleep trackers.
Spin to win Spinner icon